ORAL ABSTRACT: CT-1498 A Global Phase 1B Study of JNJ-90014496, A CD19/CD20 Bi-Specific Chimeric Antigen Receptor (Car) T-Cell Therapy, in Patients (Pts) With Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL)

Krish Patel; Joanna Rhodes; Luke Mountjoy; Jacob Haaber Christensen; Martin Hutchings; Paul Shaughnessy; Nosha Farhadfar; Constantine Tam; John Baird; Aravind Ramakrishnan; Margot Jak; Kathleen Anne Dorritie; Allison Barraclough; Daniel Morillo; Yasmina Serroukh; Matthew Schwede; Ahmed Abdulgawad; Laura Magnano Mayer; Maeve O'Reilly; John Kuruvilla; Youngil Koh; Umar Farooq; Won Seog Kim; Jacqueline Bussolari; Melissa Beelen; Julie Larsen; Mahipal Suraneni; Jianmei Wu; Leen Slaets; Alfredo Perales-Puchalt; Arnob Banerjee; Matthew Ku

doi:10.1016/S2152-2650(25)00382-9

$ORAL ABSTRACT: CT-1498 A Global Phase 1B Study of JNJ-90014496, A CD19/CD20 Bi-Specific Chimeric Antigen Receptor (Car) T-Cell Therapy, in Patients (Pts) With Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL)$

Abstract

Peer reviewed

ORAL ABSTRACT: CT-1498 A Global Phase 1B Study of JNJ-90014496, A CD19/CD20 Bi-Specific Chimeric Antigen Receptor (Car) T-Cell Therapy, in Patients (Pts) With Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL)

Krish Patel, Joanna Rhodes, Luke Mountjoy, Jacob Haaber Christensen, Martin Hutchings, Paul Shaughnessy, Nosha Farhadfar, Constantine Tam, John Baird, Aravind Ramakrishnan, …

Clinical lymphoma, myeloma and leukemia, Vol.25(Suppl 1), pp.S166-S166

09/2025

DOI: 10.1016/S2152-2650(25)00382-9

View Online

Details

Title: Subtitle: ORAL ABSTRACT: CT-1498 A Global Phase 1B Study of JNJ-90014496, A CD19/CD20 Bi-Specific Chimeric Antigen Receptor (Car) T-Cell Therapy, in Patients (Pts) With Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL)
Creators: Krish Patel - Sarah Cannon Research Institute
Joanna Rhodes - Rutgers, The State University of New Jersey
Luke Mountjoy - Colorado Blood Cancer Institute
Jacob Haaber Christensen - Odense University Hospital
Martin Hutchings - University of Copenhagen
Paul Shaughnessy - Texas Transplant Institute, San Antonio, USA
Nosha Farhadfar - Texas Transplant Institute, San Antonio, USA
Constantine Tam - Monash University
John Baird - City Of Hope National Medical Center
Aravind Ramakrishnan - St David's Medical Center
Margot Jak - University Medical Center Utrecht
Kathleen Anne Dorritie - University of Pittsburgh Medical Center
Allison Barraclough - Fiona Stanley Hospital
Daniel Morillo - Hospital Universitario Fundación Jiménez Díaz
Yasmina Serroukh - Erasmus MC
Matthew Schwede - Swedish Cancer Institute
Ahmed Abdulgawad - The Christie NHS Foundation Trust
Laura Magnano Mayer - Hospital Clínic de Barcelona
Maeve O'Reilly - University College London Hospitals NHS Foundation Trust
John Kuruvilla - Princess Margaret Cancer Centre
Youngil Koh - Seoul National University Hospital
Umar Farooq - University of Iowa
Won Seog Kim - Samsung Medical Center
Jacqueline Bussolari - Johnson & Johnson, Spring House, USA
Melissa Beelen - Johnson & Johnson, Spring House, USA
Julie Larsen - Johnson & Johnson, Los Angeles, USA
Mahipal Suraneni - Johnson & Johnson, San Diego, USA
Jianmei Wu - Johnson & Johnson, Spring House, USA
Leen Slaets - Johnson & Johnson, Spring House, Belgium
Alfredo Perales-Puchalt - Johnson & Johnson, Spring House, Spain
Arnob Banerjee - Johnson & Johnson, Spring House, USA
Matthew Ku - The University of Melbourne
Resource Type: Abstract
Publication Details: Clinical lymphoma, myeloma and leukemia, Vol.25(Suppl 1), pp.S166-S166
DOI: 10.1016/S2152-2650(25)00382-9
ISSN: 2152-2650
Publisher: Elsevier Inc
Language: English
Date published: 09/2025
Academic Unit: Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
Record Identifier: 9984949521802771

Metrics

16 Record Views